Thursday, March 24, 2016

BRIEF-Kempharm receives NDA user-fee waiver from FDA

* FDA has set a target action date under prescription drug

user fee act of June 9, 2016

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)